ALXA

Alexza Pharmaceuticals, Inc. Press Releases

$0.3198
*  
0.0198
6.6%
Get ALXA Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading ALXA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifications Panel
12/22/2015 5:00:00 PM - PR Newswire
▼-60.52 % Price Change since this news event. The Volume Ratio is 0.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 (Staccato® alprazolam) in Epilepsy Patients
12/21/2015 4:10:00 PM - PR Newswire
▼-63.66 % Price Change since this news event. The Volume Ratio is 60.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day



Learn more by visiting our FAQ page